Basel Medical Group Ltd Ordinary Shares(BMGL)

Medical - Care Facilities · Singapore, CE

$3.31+0.14 (+4.42%)

Delayed quote: Oct 6, 2026, 1:16 PM EDT

PS Ratio: N/A

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/S ratio is N/A as of 2026-10-06T17:20:54.014Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:20:54.014Z.

Quote observation: 2026-10-06T17:16:42.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 5,181,739
TTM revenue · period ending 2025-12-31: N/A

FMP input reference: 3f32b4356dd318fc5fc0a902c875af90b1a094ceb52f500a6b854293a5898a5a

P/E Ratio|Gross Margin|Revenue Growth|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BMGL PS Ratio Metrics

PS RATIO

N/A

BMGL Competitors' PS Ratio

BMGL

Basel Medical Group Ltd Ordinary Shares

Current

Market Cap

$5.18M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALZN

Alzamend Neuro Inc

vs BMGL

Market Cap

$5.21M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GELS

Gelteq Limited Ordinary Shares

vs BMGL

Market Cap

$5.22M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LIMN

Liminatus Pharma, Inc. Class A Common Stock

vs BMGL

Market Cap

$5.14M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INBS

Intelligent Bio Solutions Inc.

vs BMGL

Market Cap

$5.24M

PS Ratio

1.24

TTM Avg

1.37

3Y Avg

1.98

5Y Avg

32.27

PULM

Pulmatrix, Inc.

vs BMGL

Market Cap

$5.26M

PS Ratio

N/A

TTM Avg

1549.76

3Y Avg

519.51

5Y Avg

312.87

LNAI

Lunai Bioworks Inc.

vs BMGL

Market Cap

$5.26M

PS Ratio

251.14

TTM Avg

372.81

3Y Avg

372.81

5Y Avg

372.81

IMNN

Imunon, Inc.

vs BMGL

Market Cap

$5.04M

PS Ratio

N/A

TTM Avg

52.54

3Y Avg

81.05

5Y Avg

85.82

SNGX

Soligenix, Inc.

vs BMGL

Market Cap

$5.36M

PS Ratio

N/A

TTM Avg

41.56

3Y Avg

161.30

5Y Avg

129.34

XBIO

Xenetic Biosciences, Inc.

vs BMGL

Market Cap

$5.01M

PS Ratio

1.54

TTM Avg

1.97

3Y Avg

2.19

5Y Avg

4.13

NAME	MARKET CAP	PS RATIO	TTM	3Y	5Y
Basel Medical Group Ltd Ordinary Shares (BMGL)	$5.18M	N/A	N/A	N/A	N/A
Alzamend Neuro Inc (ALZN)vs ›	$5.21M	N/A	N/A	N/A	N/A
Gelteq Limited Ordinary Shares (GELS)vs ›	$5.22M	N/A	N/A	N/A	N/A
Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs ›	$5.14M	N/A	N/A	N/A	N/A
Intelligent Bio Solutions Inc. (INBS)vs ›	$5.24M	1.24	1.37	1.98	32.27
Pulmatrix, Inc. (PULM)vs ›	$5.26M	N/A	1549.76	519.51	312.87
Lunai Bioworks Inc. (LNAI)vs ›	$5.26M	251.14	372.81	372.81	372.81
Imunon, Inc. (IMNN)vs ›	$5.04M	N/A	52.54	81.05	85.82
Soligenix, Inc. (SNGX)vs ›	$5.36M	N/A	41.56	161.30	129.34
Xenetic Biosciences, Inc. (XBIO)vs ›	$5.01M	1.54	1.97	2.19	4.13

How this was calculated

The two-half-year calculation detail is unavailable for this stored observation.

The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.

These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.

Sales Valuation

P/S Ratio

N/A

Market Cap / Trailing Twelve-Month Revenue

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio: N/A

BMGL PS Ratio Metrics

BMGL Competitors' PS Ratio

Sales Valuation

PS Ratio Formula & Definition

Related Metrics